Immix Biopharma, Inc. IMMX Prepaid Insurance
Prepaid Insurance at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidInsurance.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s prepaid insurance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s prepaid insurance?
- Immix Biopharma, Inc. (IMMX) reported prepaid insurance of $133.51K in Q1 2026.
- How has Immix Biopharma, Inc.'s prepaid insurance changed year-over-year?
- Immix Biopharma, Inc.'s prepaid insurance decreased by 21.0% year-over-year, from $169.09K to $133.51K.
- What is the long-term trend for Immix Biopharma, Inc.'s prepaid insurance?
- Over 3 years (2022 to 2025), Immix Biopharma, Inc.'s prepaid insurance has grown at a -17.7% compound annual growth rate (CAGR), from $323.3K to $179.9K.
- What does prepaid insurance mean?
- This asset represents the unexpired portion of insurance premiums paid in advance for coverage such as directors and officers liability or clinical trial insurance. It reflects the company's proactive management of operational risk and legal liabilities. It is a standard component of working capital management for clinical-stage firms.